Category Archives: Breast Cancer

EMILIA Trial: T-DM1 in Metastatic Breast Cancer

In February 2013, the FDA approved T-DM1 (ado-trastuzumab emtansine; Kadcyla) for the treatment of patients with HER2-positive metastatic breast cancer. In this segment, panelists discuss the effectiveness of this agent and the pivotal EMILIA trial that led to its approval. Published June 24th 2013 by